# GeneXtend, LLC – FDA Inspection, Sep 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/genextend-llc/73998613-91c5-4132-a110-84df3288d026
Source feed: FDA_Inspections

> FDA inspection 1217689 of GeneXtend, LLC, September 13, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217689
- Company Name: GeneXtend, LLC
- Inspection Date: 2023-09-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1062807 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/genextend-llc/ddaed345-a1ec-4042-93bf-ad693ec786ec)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/genextend-llc/efa8624c-2ecb-4d56-804e-f40847f55404

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d